Hailing from Azerbaijan to Uruguay, the new United States citizens from 23 different countries attended the first Tompkins County Naturalization Ceremony since the pandemic.
Malnutrition of Indian children rose dramatically during the COVID-19 pandemic, according to new research from the Tata-Cornell Institute for Agriculture and Nutrition.
A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial.
Door-to-door surveillance surveys can provide more precise estimates of how many people are infected with COVID-19 or have immunity to COVID-19 at any given point in time than relying on self-reporting and self-testing, a Cornell-led research group has found.
Cornell researchers have identified a shift that occurs in canine coronavirus that points to a possible pattern of change found in other coronaviruses and which may provide clues to how they transmit to humans from animals.
While world public health agencies are focused on how to react to the next pandemic once it has started, a new plan proposes using ecological perspectives to prevent disease outbreaks before they happen.
The inflammatory response from adaptive immune cells – such as B and T lymphocytes – clears the body of the SARS-CoV-2 virus, but at the same time, it also causes the characteristic symptoms of COVID-19, a new study finds.
A team has identified an antibody that appears to block infection by all dominant variants of the virus that causes COVID-19, including omicron. Their discovery could lead to more potent vaccines and new antibody-based treatments.
New research used engineered mice to compare SARS-COV-2 omicron subvariants, and found one of them, BA.5, was more virulent likely due to its ability to rapidly replicate early during infection.